Skip to content
Antivirals — Viral protease inhibitorsATC J05AR10

Lopinavir-ritonavir

Prescription onlyWHO essential medicine

Boosted protease inhibitor for HIV, mostly used as a second-line option.

Starts working
Weeks
Half-life
5–6 hours
In use since
—
Pregnancy
Generally considered safe

Overview

Lopinavir is boosted with a low dose of ritonavir to reach effective levels. It is widely used in second-line regimens, children and pregnancy, but causes diarrhoea and lipid increases.

Conditions it's used for

How it works

Stops HIV from maturing into infectious viruses.

Lopinavir-ritonavir belongs to the Viral protease inhibitors. How Viral protease inhibitors work: block the viral 'scissors' enzyme, so the long protein chain the virus makes cannot be cut into working pieces.

Uses

  • HIV infection (with other drugs)

Available as: tablet, oral solution.

Typical dose

Adults
400/100 mg twice a day, or 800/200 mg once a day in some patients.
Children
Weight-based dosing.

Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.

Side effects

Common

Often mild and may settle with time

  • Diarrhoea
  • Nausea
  • Raised cholesterol and triglycerides
  • Tiredness

Serious — get medical help

Uncommon, but need prompt attention

  • Pancreatitis
  • Liver injury
  • QT and PR prolongation
  • Insulin resistance

Warnings

  • Interacts with many medicines
  • Lipid and glucose monitoring

Who should avoid it

  • Taking simvastatin, lovastatin, rifampicin, St John's wort
  • Severe liver disease

Interactions

  • Simvastatin, lovastatin — contraindicated
  • Rivaroxaban, apixaban — raised levels
  • Hormonal contraceptives — less reliable
  • Rifampicin — large drop in levels
  • Sildenafil, tadalafil — raised levels
  • Many other medicines

Other medicines in the atlas that need care with Lopinavir-ritonavir, grouped by the reason:

Dangerous rise in drug levelsMajorWith Ciclosporin, Colchicine, Fentanyl, Midazolam, Simvastatin and 3 more

A strong CYP3A4 inhibitor blocks breakdown of a drug where higher levels are hazardous (e.g. simvastatin — muscle breakdown; colchicine — fatal toxicity; tacrolimus — kidney damage; fentanyl or midazolam — breathing suppression).

What's usually done: Usually contraindicated or needs a planned pause or major dose change. Always check with a pharmacist.

More anticoagulant effectMajorWith Apixaban, Dabigatran, Edoxaban, Rivaroxaban

Combined P-glycoprotein and strong CYP3A4 inhibition can raise apixaban or rivaroxaban exposure and increase bleeding.

What's usually done: Follow the apixaban or rivaroxaban label: avoid or reduce the DOAC dose as directed with strong dual inhibitors.

Colchicine toxicityMajorWith Colchicine

Transporter inhibition can raise colchicine exposure; toxicity may cause severe diarrhoea, muscle injury, bone-marrow suppression or organ failure.

What's usually done: Avoid many combinations, especially with kidney or liver disease. Use a lower dose only under specialist advice.

Digoxin toxicityMajorWith Digoxin

P-glycoprotein inhibition can raise digoxin levels, increasing the risk of nausea, visual changes, confusion and dangerous heart rhythms.

What's usually done: Check the digoxin level and kidney function; a dose reduction may be needed.

Raised drug levelsModerateWith Abiraterone, Alfuzosin, Alprazolam, Amlodipine, Apremilast and 55 more
Higher rhythm riskModerateWith Amiodarone, Amisulpride, Amitriptyline, Artemether–lumefantrine, Azithromycin and 38 more
Low blood sugarModerateWith Glibenclamide, Gliclazide, Glimepiride, Glipizide

Some CYP3A4 inhibitors increase exposure to sulfonylureas, making hypoglycaemia more likely.

What's usually done: Check glucose more often and review the diabetes dose when the inhibitor starts or stops.

INR may riseModerateWith Warfarin

Some CYP3A4 inhibitors can slow warfarin metabolism and increase anticoagulant effect.

What's usually done: Check INR soon after starting or stopping the inhibitor and adjust warfarin only through the anticoagulation service.

Check Lopinavir-ritonavir against your own medicines

Using it safely

Alcohol
Best to limit. Alcohol increases pancreatitis and liver risk.
Food and drink
Tablets with or without food; solution with food.
If you miss a dose
Take when remembered; skip if near the next dose.
Stopping it
Do not stop without advice.
Driving
Dizziness and tiredness possible.
Tests and checks
Viral load; Lipids; Glucose; Liver tests; ECG if risk factors
If too much is taken
Rhythm changes and pancreatitis. Seek help.
Storage
Room temperature.
Legal status
United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule HAustralia: Prescription only (Schedule 4)

Pregnancy and breastfeeding

Pregnancy

Generally considered safe

Widely used in pregnancy within HIV regimens.

Breastfeeding

Usually avoided

Not recommended where safe formula is available.

Special groups

Liver disease
Use caution in liver disease.
Older adults
Check lipid and glucose changes.

Brand names

United States
Kaletra
United Kingdom
Kaletra
India
Lopimune, Lopinavir-ritonavir (generic)
Australia
Kaletra

Examples only; many generic versions exist. The same brand name can mean different products in different countries.

Common questions

Do I need a prescription for Lopinavir-ritonavir?

Yes — Lopinavir-ritonavir is prescription-only in most countries.

Can I take Lopinavir-ritonavir during pregnancy?

Generally considered safe. Widely used in pregnancy within HIV regimens. Always check with a doctor or midwife.

How quickly does Lopinavir-ritonavir work?

Weeks.

Sources and official information

Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.